Newbury Pharmaceuticals was founded in 2020 by Swedish Karl Karlsson. We are rapidly growing and offer a product portfolio of specialty pharma medicines with focus on the Scandinavian markets. The portfolio strategy includes niche and value-added small molecules, products based on peptide technology as well as biosimilars in a variety of therapeutic categories. The portfolio consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology representing more than 70 percent. The company was listed on Nasdaq First North, February 2022.
View Top Employees from Newbury Pharmaceuticals ABWebsite | http://www.newburypharma.com |
Employees | 12 (6 on RocketReach) |
Founded | 2020 |
Address | 1 Scheeletorget, Lund, Skane 223 81, SE |
Phone | (464) 612-1120 |
Technologies |
HTML,
Twitter,
Google Analytics
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 33 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Newbury Pharmaceuticals AB employee's phone or email?
Fredrik Hellqvist is the Vice President - Sales and Marketing of Newbury Pharmaceuticals AB.
6 people are employed at Newbury Pharmaceuticals AB.
Newbury Pharmaceuticals AB is based in Lund, Skane.
The NAICS codes for Newbury Pharmaceuticals AB are [32, 33, 3254, 325].
The SIC codes for Newbury Pharmaceuticals AB are [28, 2834, 283].